SKI Market

A+| A| A-|

Indian Indices

Sensex

71,947.55 -1,635.67
( -2.22%)

Global Indices

Nasdaq

45,242.12 54.47
(0.12%)

Dow Jones

6,365.58 -24.27
(-0.38%)

Hang Seng

51,264.29 -621.56
(-1.20%)

Nikkei 225

10,176.45 48.49
(0.48%)

Forex

USD-INR

94.53 0.44
(0.47%)

EUR-INR

108.77 0.13
(0.12%)

GBP-INR

125.32 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540694

INE236W01016

49.9768362

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

24.05

EPS(TTM)

Face Value()

Div & Yield %

Back

AG Ventures reports consolidated net profit of Rs 0.20 crore in the September 2025 quarter

Nov 13,2025

Net profit of AG Ventures remain constant at Rs 0.20 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024. Sales declined 6.73% to Rs 29.95 crore in the quarter ended September 2025 as against Rs 32.11 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	29.95	32.11	-7
OPM %	5.24	15.66	-
PBDT	2.33	5.66	-59
PBT	1.27	4.70	-73
NP	0.20	0.20	0

71,947.55 -1,635.67 ( -2.22%)

45,242.12 54.47 (0.12%)

6,365.58 -24.27 (-0.38%)

51,264.29 -621.56 (-1.20%)

10,176.45 48.49 (0.48%)

94.53 0.44 (0.47%)

108.77 0.13 (0.12%)

125.32 -0.25 (-0.20%)

0.59 0.00 (-0.02%)